Cabot C, del Mar Grasa M, Estruch J, Fernández-López J A, Remesar X, Alemany M
Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Spain.
Brain Res Bull. 1998 Aug;46(6):529-34. doi: 10.1016/s0361-9230(98)00050-1.
Adult female Zucker lean and obese rats were treated for 14 days with 3.5 nm/kg oleoyl-estrone (OE) in liposomes (Merlin-2) through continuous i.v. injection with osmotic minipumps. Rat wt. and food intake were measured daily. On days 0, 3, 6, 10, and 14, groups of rats were killed and their hypothalamic nuclei [lateral preoptic (LPO), median preoptic (MPO), paraventricular (PVN), ventromedial (VMH), and arcuate (ARC)] were dissected, homogenized, and used for the measurement of corticosterone-releasing hormone (CRH) by radioimmunoassay. The OE treatment decreased food intake by 67.4% in lean and 62.6% in obese rats (means for 14 days). Body wt. decreased steadily in lean and obese rats, the gap between controls and treated rats becoming 11.5% of initial body wt. in the lean and 12.4% in the obese. The levels of CRH in the ARC nucleus were at least 10-fold higher than in the other nuclei. No changes in CRH were observed in any of the nuclei of obese rats, with levels up to day 6 similar to those of lean rats. In the lean rats, the LPO and ARC nuclei showed peaks on day 10, while the MPO showed no changes and the PVN and VMH nuclei showed a progressive increase, to a maximum at the end of the study (day 14). This contrasted with the peak of plasma adrenocorticotropic hormone (ACTH) and corticosterone (day 6 in lean and day 14 in obese rats). There was a definite lack of correlation between the plasma levels of these two hormones and the levels of CRH in the hypothalamic nuclei, and between the latter and the decreases in appetite in the rats. The loss of appetite induced by OE is not necessarily mediated by CRH, because the obese rats show an intense decrease in voluntary food intake but their hypothalamic nuclei CRH levels do not change at all. Hypothalamic nuclei CRH does not, necessarily, mediate the rise in glucocorticoids induced by OE treatment, because this is observed in lean and obese rats, lean rats increases being mismatched with those of hypothalamic CRH. The OE induced changes in hypothalamic CRH require a fully functional leptinergic pathway, because it is not observed in Zucker fa/fa rats lacking a working leptin receptor. This--indirectly--shows that leptin is needed for its synthesis or modulation.
成年雌性Zucker瘦型和肥胖型大鼠通过渗透微型泵连续静脉注射脂质体(Merlin - 2)中3.5 nmol/kg的油酰雌酮(OE),持续治疗14天。每天测量大鼠体重和食物摄入量。在第0、3、6、10和14天,处死几组大鼠,解剖其下丘脑核团[外侧视前核(LPO)、正中视前核(MPO)、室旁核(PVN)、腹内侧核(VMH)和弓状核(ARC)],匀浆后用于通过放射免疫测定法测量促肾上腺皮质激素释放激素(CRH)。OE治疗使瘦型大鼠的食物摄入量减少了67.4%,肥胖型大鼠减少了62.6%(14天的平均值)。瘦型和肥胖型大鼠的体重稳步下降,对照组和治疗组大鼠之间的差距在瘦型大鼠中变为初始体重的11.5%,在肥胖型大鼠中变为12.4%。ARC核中的CRH水平比其他核至少高10倍。肥胖型大鼠的任何核团中均未观察到CRH的变化,直到第6天其水平与瘦型大鼠相似。在瘦型大鼠中,LPO和ARC核在第10天出现峰值,而MPO无变化,PVN和VMH核呈逐渐增加趋势,在研究结束时(第14天)达到最大值。这与血浆促肾上腺皮质激素(ACTH)和皮质酮的峰值形成对比(瘦型大鼠在第6天,肥胖型大鼠在第14天)。这两种激素的血浆水平与下丘脑核团中CRH的水平之间,以及后者与大鼠食欲下降之间明显缺乏相关性。OE诱导的食欲减退不一定由CRH介导,因为肥胖型大鼠的自愿食物摄入量大幅下降,但其下丘脑核团中的CRH水平根本没有变化。下丘脑核团CRH不一定介导OE治疗诱导的糖皮质激素升高,因为在瘦型和肥胖型大鼠中均观察到这种情况,瘦型大鼠的升高与下丘脑CRH的升高不匹配。OE诱导的下丘脑CRH变化需要完整的瘦素能通路,因为在缺乏正常瘦素受体的Zucker fa/fa大鼠中未观察到这种情况。这——间接——表明瘦素对于其合成或调节是必需的。